These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 2961218)
21. The role of extracellular Ca2+ and Na+ in paf-acether-induced human platelet activation. Keraly CL; Delautier D; Benveniste J Biochem Pharmacol; 1989 Oct; 38(20):3415-21. PubMed ID: 2818633 [TBL] [Abstract][Full Text] [Related]
22. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro. Bode-Böger SM; Böger RH; Galland A; Frölich JC Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487 [TBL] [Abstract][Full Text] [Related]
23. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways. Lauri D; Cerletti C; de Gaetano G J Lab Clin Med; 1985 Jun; 105(6):653-8. PubMed ID: 3923145 [TBL] [Abstract][Full Text] [Related]
24. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine. Zeng S; Guo ZG Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970 [TBL] [Abstract][Full Text] [Related]
25. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. Altman R; Scazziota A Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757 [TBL] [Abstract][Full Text] [Related]
26. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood. Anfossi G; Trovati M; Mularoni E; Massucco P; Calcamuggi G; Emanuelli G Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):1-7. PubMed ID: 2525784 [TBL] [Abstract][Full Text] [Related]
27. Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation. Macconi D; Viganò G; Bisogno G; Galbusera M; Orisio S; Remuzzi G; Livio M Am J Kidney Dis; 1992 Apr; 19(4):318-25. PubMed ID: 1562019 [TBL] [Abstract][Full Text] [Related]
28. Platelet activating factor (PAF) causes human platelet aggregation through the mechanism of membrane modulation. Rao GH; White JG Prostaglandins Leukot Med; 1982 Oct; 9(4):459-72. PubMed ID: 6817343 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of PAF-induced activation of human platelets by verapamil. Smith IL; Smith EA Blood Coagul Fibrinolysis; 1992 Dec; 3(6):759-63. PubMed ID: 1336985 [TBL] [Abstract][Full Text] [Related]
30. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine. Stuart MJ; Dusse J; Clark DA; Walenga RW Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080 [TBL] [Abstract][Full Text] [Related]
31. Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. Nunn B Thromb Res; 1983 Sep; 31(5):657-63. PubMed ID: 6648898 [TBL] [Abstract][Full Text] [Related]
32. Effect of storage on platelet release and aggregation responses. Scott NJ; Harris JR; Bolton AE Vox Sang; 1983; 45(5):359-66. PubMed ID: 6227139 [TBL] [Abstract][Full Text] [Related]
33. Kinetics of the beta-thromboglobulin release from alpha-granules of blood platelets activated by ADP. Walkowiak B; Cierniewski CS Thromb Res; 1987 Jun; 46(5):727-36. PubMed ID: 2957817 [TBL] [Abstract][Full Text] [Related]
34. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Krishnamurthi S; Joseph S; Kakkar VV Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746 [TBL] [Abstract][Full Text] [Related]
35. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro. Wang LL; Mei QB; Zhao DH; Guo ZA Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670 [TBL] [Abstract][Full Text] [Related]
36. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446 [TBL] [Abstract][Full Text] [Related]
37. Aggregating and prostanoid-releasing effects of platelet-activating factor and leukotrienes on human polymorphonuclear leukocytes and platelets. Dahl ML Int Arch Allergy Appl Immunol; 1985; 76(2):145-50. PubMed ID: 2981776 [TBL] [Abstract][Full Text] [Related]
38. Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. Powling MJ; Hardisty RM Thromb Haemost; 1988 Apr; 59(2):212-5. PubMed ID: 3388294 [TBL] [Abstract][Full Text] [Related]
39. Dual effects of oleic acid on Ca2+ mobilization and protein phosphorylation in human platelets in presence or absence of platelet activating factor. Kimoto M; Javors MA; Ekholm J; Siafaka-Kapadai A; Hanahan DJ Arch Biochem Biophys; 1992 Nov; 298(2):471-9. PubMed ID: 1384432 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Shah BH; Nawaz Z; Pertani SA; Roomi A; Mahmood H; Saeed SA; Gilani AH Biochem Pharmacol; 1999 Oct; 58(7):1167-72. PubMed ID: 10484074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]